By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cerecor Inc. 

2400 Boston Street, Suite 324

Baltimore  Maryland  21224  U.S.A.
Phone: 410-522-8707 Fax: n/a


Start Up

Company News
Cerecor Inc. Announces Initiation Of Phase II Clinical Trial With CERC-501 For Smoking Cessation 2/2/2016 10:57:09 AM
Cerecor Inc. To Present At The BIO CEO & Investor Conference In New York City 2/1/2016 10:46:43 AM
Cerecor Inc. Announces Publication Describing Antidepressant Activity Of CERC-301 In Preclinical Model 1/19/2016 8:03:56 AM
Cerecor Inc. Appoints Thomas Aasen To Board Of Directors 1/12/2016 11:22:33 AM
Cerecor Inc. To Present At Biotech Showcase 2016 In San Francisco 1/4/2016 7:55:48 AM
Former Roche (RHHBY) Exec Joins Cerecor Inc. as New CEO 12/21/2015 7:43:09 AM
Publication Reports Human Brain Penetration And Target Engagement Of Cerecor Inc.’s Oral Kappa Opioid Receptor Antagonist, CERC-501 12/11/2015 8:28:45 AM
Cerecor Inc. Announces Separation Of Units Sold In IPO 11/13/2015 12:24:29 PM
Cerecor Inc. Announces Pricing Of Initial Public Offering 10/15/2015 8:28:57 AM
Cerecor Inc. Initiates Phase II Study For CERC-301, An Antidepressant Product Candidate With Potential For Rapid Onset Of Effect 9/3/2015 10:51:50 AM